###begin article-title 0
###xml 20 36 20 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 49 55 <span type="species:ncbi:10090">murine</span>
Characterization of TEM1/endosialin in human and murine brain tumors
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 118 134 118 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 229 234 <span type="species:ncbi:9606">human</span>
###xml 257 262 <span type="species:ncbi:10090">mouse</span>
TEM1/endosialin is an emerging microvascular marker of tumor angiogenesis. We characterized the expression pattern of TEM1/endosialin in astrocytic and metastatic brain tumors and investigated its role as a therapeutic target in human endothelial cells and mouse xenograft models.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ </italic>
###xml 105 121 105 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 222 238 222 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 337 345 337 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 418 434 418 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 307 312 <span type="species:ncbi:9606">human</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
In situ hybridization (ISH), immunohistochemistry (IH) and immunofluorescence (IF) were used to localize TEM1/endosialin expression in grade II-IV astrocytomas and metastatic brain tumors on tissue microarrays. Changes in TEM1/endosialin expression in response to pro-angiogenic conditions were assessed in human endothelial cells grown in vitro. Intracranial U87MG glioblastoma (GBM) xenografts were analyzed in nude TEM1/endosialin knockout (KO) and wildtype (WT) mice.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 231 247 231 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 283 299 283 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 368 384 368 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 544 552 540 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 554 570 550 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 644 660 640 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 724 740 720 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 862 878 858 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 425 432 <span type="species:ncbi:9606">patient</span>
###xml 589 594 <span type="species:ncbi:9606">human</span>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
TEM1/endosialin was upregulated in primary and metastatic human brain tumors, where it localized primarily to the tumor vasculature and a subset of tumor stromal cells. Analysis of 275 arrayed grade II-IV astrocytomas demonstrated TEM1/endosialin expression in 79% of tumors. Robust TEM1/endosialin expression occurred in 31% of glioblastomas (grade IV astroctyomas). TEM1/endosialin expression was inversely correlated with patient age. TEM1/endosialin showed limited co-localization with CD31, alphaSMA and fibronectin in clinical specimens. In vitro, TEM1/endosialin was upregulated in human endothelial cells cultured in matrigel. Vascular Tem1/endosialin was induced in intracranial U87MG GBM xenografts grown in mice. Tem1/endosialin KO vs WT mice demonstrated equivalent survival and tumor growth when implanted with intracranial GBM xenografts, although Tem1/endosialin KO tumors were significantly more vascular than the WT counterparts.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 155 171 155 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 291 307 291 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 125 132 <span type="species:ncbi:9606">patient</span>
TEM1/endosialin was induced in the vasculature of high-grade brain tumors where its expression was inversely correlated with patient age. Although lack of TEM1/endosialin did not suppress growth of intracranial GBM xenografts, it did increase tumor vascularity. The cellular localization of TEM1/endosialin and its expression profile in primary and metastatic brain tumors support efforts to therapeutically target this protein, potentially via antibody mediated drug delivery strategies.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 698 699 698 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 887 902 887 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin</italic>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
###xml 172 177 <span type="species:ncbi:54556">bleak</span>
Despite advances in neurosurgical techniques, chemotherapeutic regimens and radiotherapy protocols, the prognosis for patients suffering from malignant astrocytoma remains bleak. Novel treatment approaches are required which attack the unique molecular and biological features that contribute to the growth of these tumors. A particularly promising target is the abnormal tumor vasculature, which represents one of the defining characteristics of the most malignant and common astrocytoma, glioblastoma multiforme (GBM). We previously compared the gene expression profile of endothelial cells isolated from freshly resected GBMs with that of endothelium isolated from non-neoplastic temporal lobe [1]. These experiments and subsequent studies identified 21 genes that met the statistical requirements as putative glioma endothelial markers (GEMS). One especially promising candidate was TEM1/endosialin.
###end p 10
###begin p 11
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1 </italic>
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1 </italic>
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 270 286 270 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 443 459 443 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 736 752 736 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 950 966 950 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1099 1115 1099 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1200 1216 1200 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
###xml 829 834 <span type="species:ncbi:9606">human</span>
###xml 969 973 <span type="species:ncbi:10090">mice</span>
TEM1 was identified in the tumor endothelium of human colon carcinoma [2]. Soon after, it was recognized that TEM1 encoded endosialin, which corresponded to the tumor vascular endothelial antigen recognized by the FB5 antibody [3,4]. Further analyses revealed selective TEM1/endosialin expression in tumor endothelium, pericytes and a subset of fibroblast-like cells of tumor stroma in breast carcinoma, anaplastic astrocytoma and GBM [5-10]. TEM1/endosialin encodes a transmembrane glycoprotein and putative membrane receptor. Recent evidence suggests it may interact with extracellular matrix components including collagen I, collagen IV and fibronection, as well as Mac-2 BP/90K in promoting vascular migration and invasion [11,12]. Tem1/endosialin knockout (KO) mice are fertile and appear to develop normally. However, when human HCT116 colon carcinoma cells were implanted orthotopically onto the serosal surface of the large intestine of nude Tem1/endosialin KO mice, both tumor take and growth were inhibited while the number of tumor microvessels increased [13]. The selective induction of TEM1/endosialin in malignant gliomas, its cell surface bioavailability and the evidence that lack of TEM1/endosialin can disrupt tumor growth and vascular differentiation in a xenograft model combine to make it a potential target for molecular therapy.
###end p 11
###begin p 12
###xml 79 95 79 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 204 220 204 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 355 371 355 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 418 425 418 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 443 459 443 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 743 751 743 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 753 769 753 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 880 896 880 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 987 1003 987 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 1085 1101 1085 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 1132 1148 1132 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1308 1324 1308 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 1373 1389 1373 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 611 618 <span type="species:ncbi:9606">patient</span>
###xml 801 806 <span type="species:ncbi:9606">human</span>
###xml 1104 1108 <span type="species:ncbi:10090">mice</span>
###xml 1392 1396 <span type="species:ncbi:10090">mice</span>
We sought to expand these preliminary findings by examining the specificity of TEM1/endosialin expression in a larger collection of primary and secondary brain tumors. We also wished to determine whether TEM1/endosialin induction in brain tumors was conserved in a commonly used U87MG intracranial xenograft model. Finally, we wished to determine whether TEM1/endosialin expression was required for brain tumor growth in vivo. We confirm that TEM1/endosialin is induced, primarily in the vascular compartment, in a wide range of both low-grade and high-grade cerebral neoplasms and is inversely correlated with patient age. TEM1/endosialin shows limited co-localization with fibronectin, a putative binding partner, in malignant brain tumors. In vitro, TEM1/endosialin expression can be stimulated in human microvascular endothelial cells grown in matrigel. Finally, we show that Tem1/endosialin upregulation occurs in the tumor vasculature of intracranial GBM xenografts and absence of Tem1/endosialin is associated with increased numbers of microvessels within tumors explanted from Tem1/endosialin KO mice, supporting a role for TEM1/endosialin in the migration and maturation of the brain tumor vasculature. However, despite its conserved expression pattern in the tumor cerebrovasculature, we find that Tem1/endosialin is not required for intracranial tumor growth in Tem1/endosialin KO mice.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Clinical specimens
###end title 14
###begin p 15
###xml 466 474 <span type="species:ncbi:9606">patients</span>
Clinical specimens were provided by the Brain Tumor Bank of the University of Pittsburgh as approved by the University of Pittsburgh Institutional Review Board and the Neurosurgical Brain Tissue Bank of the University of Rochester as approved by the University of Rochester Research Subjects Review Board. All samples were deidentified according to HIPAA regulations prior to being provided for this research. Astrocytoma array materials were obtained from surgical patients at Tampere University Hospital, Tampere, Finland, in 1983-2002, in accordance with the Research Ethics Committee of Tampere University Hospital.
###end p 15
###begin title 16
RNA isolation and reverse transcription
###end title 16
###begin p 17
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 186 188 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sup>
RNA isolations and reverse transcription was performed as previously described [14]. In brief, total RNA was isolated from 10-30 mg of snap frozen, homogenized tissue or approximately 106 cultured cells using the Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA) according to manufacturer's protocol. cDNA was generated using the SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA) according to manufacturer's protocol.
###end p 17
###begin title 18
PCR amplification
###end title 18
###begin p 19
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
All PCR primers were generated by IDT (Integrated DNA Technologies, Coralville, IA). Sequences available upon request. PCR reactions were performed using Platinum Taq Polymerase (Invitrogen) as previously described [14]. Reactions were cycled in a PTC-200 DNA Engine thermalcycler (MJ Research, Waltham, MA). Primers for vWF were used for normalization.
###end p 19
###begin title 20
Quantitative RT-PCR amplification
###end title 20
###begin p 21
###xml 654 656 634 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct</italic>
###xml 772 775 752 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct </italic>
###xml 796 812 776 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 826 829 806 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct </italic>
###xml 833 836 813 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vWF</italic>
###xml 865 868 845 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e</italic>
###xml 871 879 851 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;Ct</sup>
###xml 898 914 874 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
qRT-PCR was carried out on triplicate samples for 40 cycles of 10 s at 95degreesC, 30 s at 60degreesC after an initial incubation at 95degreesC for 3 min in an Chromo4 thermal cycler (Bio-Rad, Hercules, CA). Reaction conditions were 1x iQ SYBR Green super mix (Bio-Rad), 400 nM forward and reverse primers, and 2.0 mul cDNA in a total reaction volume of 25 mul. Amplification of vWF was performed for each cDNA in triplicate for normalization of vascular RNA content. Primer sequences were: TEM1 (F)5'-ctacgttggtggcttcgagt-3'; TEM1(R)5'-caggcctcgtcttcatcttc-3'; vWF(F)5'-cacatcgtgacctttgatgg-3'; vWF(R)5'-gtgcttcacctcgatggatt-3'. Threshold cycle number (Ct) of amplification in each sample was determined by Bio-Rad software. Relative mRNA abundance was calculated as the Ct for amplification of TEM1/endosialin minus average Ct for vWF, expressed as a power of 2, i.e. 2-DeltaCt. Three individual TEM1/endosialin values were averaged to obtain mean +/- SD. Statistical significance was determined using a Wilcoxon rank sum test.
###end p 21
###begin title 22
In situ hybridization
###end title 22
###begin p 23
###xml 28 30 28 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 184 193 184 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro </italic>
###xml 703 709 <span type="species:ncbi:9986">rabbit</span>
###xml 839 845 <span type="species:ncbi:9986">rabbit</span>
###xml 1034 1038 <span type="species:ncbi:9925">goat</span>
###xml 1210 1214 <span type="species:ncbi:9925">goat</span>
Protocol was modified from [14]. Briefly, probe templates blanketing the target cDNA were generated by PCR amplification with incorporation of a T7 promoter into the antisense primer. In vitro transcription was performed using the DIG RNA Labeling Kit (SP6/T7) and T7 RNA polymerase (Roche, Indianapolis, IN) according to manufacturer's protocol. Sections were deparaffinized in xylenes and rehydrated in graded ethanols. DIG-labeled RNA probe cocktails were diluted to 200 ng/ml in RNA hybridization solution (EMD Bioscience, Madison, WI) and hybridized to slides overnight at 55degreesC. Slides were treated with RNase A/T1 (Ambion, Austin, TX) and stringently washed. Slides were blocked with normal rabbit IgG (Dako) diluted 1:20 in buffer (100 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% casein). For detection, sections were incubated with rabbit HRP-anti-DIG primary (Dako) diluted 1:150 in blocking buffer. Signal was amplified by incubating each slide with one drop of biotinyl-tyramide (Dako). Slides were washed then incubated in goat HRP-anti-biotin secondary (1:100, Vector Laboratories, Burlingame, CA) in blocking buffer. Amplification with biotinyl-tyramide was repeated. Sections were incubated with goat AP-anti-biotin tertiary (1:100, Vector) in blocking buffer and washed. Signal was detected by staining with Fast Red (Sigma-Aldrich, St. Louis, MO) followed by counterstaining with Probe/Hematoxylin counterstain (Biomeda, Foster City, CA). Slides were mounted with Crystal/Mount (Biomeda). Images were captured with an Olympus BH-2 microscope using Spot Insight Color model 3.2.0 camera and Spot Advanced software (Diagnostic Instruments, Sterling Heights, MI).
###end p 23
###begin title 24
Antibodies
###end title 24
###begin p 25
###xml 30 36 <span type="species:ncbi:9986">rabbit</span>
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 193 197 <span type="species:ncbi:9925">goat</span>
###xml 305 311 <span type="species:ncbi:9986">Rabbit</span>
###xml 362 366 <span type="species:ncbi:9925">Goat</span>
###xml 372 378 <span type="species:ncbi:9986">rabbit</span>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
###xml 546 551 <span type="species:ncbi:10090">mouse</span>
###xml 593 598 <span type="species:ncbi:10090">mouse</span>
###xml 698 704 <span type="species:ncbi:9986">rabbit</span>
###xml 736 740 <span type="species:ncbi:9925">goat</span>
TEM1/33, an affinity purified rabbit polyclonal antibody to human TEM1/endosialin, was raised against the peptide RLGFRPAEDDPHRCVDT (Quality Controlled Biochemicals, Hopkinton, MA). Additional goat anti-TEM1/endosialin antibodies sc-48097 and sc-48098 were from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit-anti-vWF (ab6994) was from Abcam (Cambridge, MA). Goat anti-rabbit-HRP secondary antibody was from Jackson ImmunoResearch Laboratories (West Grove, PA). For immunofluorescence, mouse anti-alpha smooth muscle actin (alphaSMA) (Sigma), mouse anti-CD31 (Zymed, San Francisco, CA) and mouse anti-fibronectin (FN) (Sigma) were used. Secondary antibodies for immunofluorescence included anti-rabbit Alexa Fluor 568 (red) and anti-goat Alexa Fluor 488 (green) (Invitrogen).
###end p 25
###begin title 26
Immunohistochemistry
###end title 26
###begin p 27
###xml 133 134 133 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 135 137 135 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 805 806 799 800 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 236 240 <span type="species:ncbi:9925">goat</span>
###xml 279 285 <span type="species:ncbi:9986">rabbit</span>
###xml 417 421 <span type="species:ncbi:9925">goat</span>
###xml 427 433 <span type="species:ncbi:9986">rabbit</span>
Sections were deparaffinized in xylenes and rehydrated in graded ethanols. Slides were washed in 1x PBS and then quenched with 0.3% H202 in 0.3% normal serum/1x PBS for 5 minutes. Slides were washed in 1x PBS and blocked with 4% normal goat serum 1xPBS. Sections were exposed to rabbit polyclonal anti-TEM1 (1:50) or anti-vWF (1:500) at 4degreesC overnight. Sections were washed with 1x PBS and exposed for 1 hour to goat-anti-rabbit secondary, diluted 1:300. Sections were washed in 1x PBS then exposed to Vectastain-Elite ABC (Vector) for 30 minutes. Sections were washed in 1x PBS and incubated with NovaRed substrate (Vector). Slides were rinsed with distilled water and counterstained with Mayer's Hematoxylin (Biomeda, Foster City, CA). Sections were rinsed with distilled water, exposed to 0.08% NH4OH for 3 minutes, rinsed with distilled water and mounted with Crystal/Mount. Images were captured as described above.
###end p 27
###begin title 28
Astrocytoma array
###end title 28
###begin p 29
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 307 323 303 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 350 358 346 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ </italic>
###xml 239 246 <span type="species:ncbi:9606">Patient</span>
Tumor specimens were fixed in 4% phosphate-buffered formaldehyde and processed into paraffin embedded tissue microarrays as previously described [15]. 275 samples were included in the analyses: 39 grade II, 41 grade III, and 195 grade IV. Patient age ranged from 3 to 80 years (mean +/- SD: 50.4 +/- 15.2). TEM1/endosialin expression was assessed by in situ hybridization as described above. Statistical analyses, including Mann-Whitney and Kruskal-Wallis tests to correlate expression to age, were performed using SPSS 11.0 for Windows (SPSS, Chicago, IL).
###end p 29
###begin title 30
Immunofluorescence
###end title 30
###begin p 31
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 455 461 <span type="species:ncbi:9793">donkey</span>
Slides were deparaffinzed in xylenes and rehydrated in graded ethanols and rinsed in dH2O as described above. For TEM1/CD31, slides were boiled for 15 minutes in citrate buffer (Zymed), cooled for 20 minutes, then washed in PBS for 5 minutes. TEM1/alphaSMA staining did not require antigen retrieval. For TEM1/FN staining, slides were incubated with 0.1% proteinase K at 37degreesC for 15 minutes. Slides were washed in PBS and the blocked with 5% normal donkey serum containing 3% BSA in PBS for 30 minutes. Slides were incubated with primary antibodies diluted 1:10 (TEM1/33), 1:20 (CD31), 1:50 (alphaSMA) or 1:100 (FN) in blocking buffer at 37degrees for 1 hour. Slides were then rinsed with PBS and incubated with the appropriate secondary in diluted 1:200 in normal host serum for 1 hour at 37degreesC in the dark. Slides were rinsed in PBS before the addition of ToPro3 nuclear stain (Invitrogen) and then mounted with Prolong Gold mounting media (Invitrogen). Confocal images were captured using Zeiss LSM 510 Axioskop 2 microscope (Zeiss Microimaging, Thornwood, NY) and analyzed with Zen 2007 software (Zeiss).
###end p 31
###begin title 32
Cell lines and culture conditions
###end title 32
###begin p 33
###xml 346 347 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 744 746 743 745 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 1258 1260 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 144 149 <span type="species:ncbi:9606">Human</span>
Human primary brain microvascular endothelial cells (HPBMEC) (Cell Systems, Kirkland, WA) were maintained in CSC-Complete media (Cell Systems). Human dermal microvascular endothelial cells (HMVEC) (Lonza, Walkersville, MD) were maintained in EBM/EGM-2MV growth media with 1x growth supplements (hEGF, hydrocortisone, GA-1000, FBS, VEGF, hFGF-B, R3-IGF-1, and ascorbic acid) (Cambrex). U87MG tumor cells (ATCC, Manassas, VA) were maintained in Minimum Essential Medium Eagle with Earle's Salts and L-glutamine (Invitrogen, Carlsbad, CA), supplemented with 10% FBS, 0.1 mM MEM non-essential amino acids, 0.1 mM MEM sodium pyruvate, sodium bicarbonate, 1 unit/ml penicillin, and 1 mug/ml streptomycin (Invitrogen). Cells were maintained in a 5% CO2 atmosphere at 37degreesC. Endothelial cells were used at passage 3-7 in all experiments. For growth factor experiments, endothelial cells were cultured in the presence of 25 ng/ml VEGF (Sigma), 10 ng/ml TGFbeta(R&D Systems), 100 ng/ml IGF-1 (Upstate, Billerica, MA), 50 ng/ml SDF-1 (Biosource, Carlsbad, CA), 20 ng/ml SCF (Biosource) or 50 ng/ml SF/HGF (Biosource) for 48 hours prior to harvest and RNA isolation. Culture of endothelial cells in matrigel (BD Bioscience, Bedford, MA) was performed as described [14]. Cells were harvested from matrigel using Cell Recovery Solution (BD Bioscience) according to manufacturer's protocol. In brief, the cell/matrigel layer was transferred to a 50 ml tube and 4 ml of Cell Recovery Solution was added. The mixture was incubated on ice to completely dissociate the matrigel and release the cells, which were then collected by centrifugation, washed twice in PBS and used for RNA isolation.
###end p 33
###begin title 34
Intracranial xenografts
###end title 34
###begin p 35
###xml 93 95 93 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5 </sup>
###xml 228 244 227 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 297 299 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 461 463 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">Mice</span>
###xml 466 470 <span type="species:ncbi:10090">Mice</span>
###xml 523 527 <span type="species:ncbi:10090">Mice</span>
U87MG cells were harvested with trypsin (Invitrogen) and resuspended at a concentration of 105 cells/10 mul antibiotic-free DMEM. Athymic nu/nu mice were purchased from the National Cancer Institute (Frederick, MD) and the nude Tem1/endosialin KO and WT mice were derived as previously described [13]. Mice were anesthetized using an intraperitoneal injection of 3 ml/kg xylazine/ketamine and tumor cells were stereotactically injected as previously described [16]. Mice were observed daily and survival time was recorded. Mice were euthanized by barbituate overdose when they exhibited symptoms of tumor burden or distress. Brains were surgically removed, formalin fixed and embedded in paraffin. All procedures were approved by the Institutional Animal Care and Usage Committees of the Johns Hopkins University School of Medicine and the University of Rochester.
###end p 35
###begin title 36
Vessel counts
###end title 36
###begin p 37
###xml 186 202 186 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 211 227 211 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
Tumor sections were immunostained for vWF, as described above. Vessels were counted in 10 non-overlapping, 400x fields (5 fields each from two anatomically distinct tumor regions), in 6 Tem1/endosialin WT and 6 Tem1/endosialin KO xenograft tumors. Statistical significance was determined by Wilcoxon rank sum test.
###end p 37
###begin title 38
Results
###end title 38
###begin title 39
TEM1/endosialin is upregulated in both primary and secondary brain tumors
###end title 39
###begin p 40
###xml 62 78 62 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 195 211 195 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 315 331 315 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 743 759 743 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 903 919 903 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 121 126 <span type="species:ncbi:9606">human</span>
Our previous SAGE data and studies from others indicated that TEM1/endosialin was upregulated in the microvasculature of human GBMs and a subset of brain tumors [1,5,7]. In order to confirm that TEM1/endosialin induction was common to both primary and secondary brain tumors, we performed quantitative RT-PCR using TEM1/endosialin specific primers on mRNA isolated from frozen clinical specimens of 2 non-neoplastic brain tissues and 5 GBMs, as well as 5 specimens of metastatic lung adenocarcinoma resected from brain. Reactions were normalized to vWF in order to account for the increased vascularity of the tumor specimens. Representative standard RT-PCR data are shown in Fig 1A. Quantitative RT-PCR results confirmed that upregulation of TEM1/endosialin is detectable in whole tissue from both primary and secondary brain tumor samples as compared to non-neoplastic controls and support a role for TEM1/endosialin as an angiogenic marker for CNS neoplasia (Fig 1B).
###end p 40
###begin p 41
###xml 16 32 16 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Localization of <italic>TEM1/endosialin </italic>expression</bold>
###xml 73 89 73 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 356 372 356 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 497 513 497 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 595 603 595 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ </italic>
Localization of TEM1/endosialin expression. A. Representative RT-PCR for TEM1/endosialin (TEM1) in whole cell lysates from two GBMs (T1, T2), two metastatic brain tumors (T3, T4) and two non-neoplastic controls (N1, N2). Expression was normalized to von Willebrand Factor (vWF), an endothelial positive control. B. Combined quantitative RT-PCR results for TEM1/endosialin in two controls (N), five GBMs (GBM) and five metastatic tumors (Met). Error bars, standard error of the mean. *p = 0.05. C. TEM1/endosialin was visualized by immunohistochemistry (IHC) using the TEM1/33 custom antibody or in situ hybridization (ISH) in glioblastoma (GBM), metastatic brain tumor (MET) and non-neoplastic brain tissues (Normal). Staining for vWF was used as an endothelial positive control. Original magnification for whole spot, 40x; detail, 100x.
###end p 41
###begin p 42
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ </italic>
###xml 86 102 86 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1C</xref>
###xml 423 439 423 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 675 691 675 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 825 826 825 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 895 911 895 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 977 993 977 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1230 1245 1230 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin</italic>
###xml 1296 1297 1296 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1329 1345 1329 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1504 1520 1504 1520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1570 1586 1570 1586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
We next used in situ hybridization and immunohistochemistry to localize expression of TEM1/endosialin mRNA and protein (Fig 1C) using an independent array of 7 non-neoplastic (reactive) brain tissue specimens, 4 pilocytic astrocytomas, 7 metastatic adenocarcinomas (3 lung adenocarcinomas, 1 lung adenosquamous carcinoma, 1 non-small cell lung carcinoma, 1 esophageal adenocarcinoma and 1 colon adenocarcinoma) and 9 GBMs. TEM1/endosialin expression was detected in the vasculature of both GBMs and metastatic brain tumors, as compared to the endothelial control marker, vWF. In GBMs, 3/9 tumors or approximately 33% of the tissues demonstrated a robust staining pattern for TEM1/endosialin (nearly 100% of vessels positive), while another 2/9 tumors showed moderate expression (approximately 50% of vessels positive) (Table 1). Similarly, 2/7 metastatic tumors (28%) showed robust staining for TEM1/endosialin while another 2/7 (28%) demonstrated a moderate staining pattern. TEM1/endosialin expression was occasionally noted in a subset of tumor stromal cells. Little to no staining was detected in reactive (non-neoplastic) brain tissue. Thus, high-grade primary and secondary brain tumors show similar expression profiles for TEM1/endosialin. These numbers are consistent with previous work [7], and suggest that the role of TEM1/endosialin is critical for vessel development in the brain, regardless of the tumor tissue of origin. Interestingly, 1 of 4 pilocytic astrocytoma specimens showed robust TEM1/endosialin expression while the remaining 3 had little to no TEM1/endosialin reactivity. Pilocytic astrocytomas are low-grade astrocytomas, but can be highly angiogenic and often demonstrate enhancement and blood-brain barrier disruption on MRI scans.
###end p 42
###begin p 43
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
TEM1/endosialin and fibronectin expression levels in brain tissue microarray.
###end p 43
###begin p 44
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTE</italic>
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
NOTE: Non-neoplastic control tissue (Control), pilocytic astrocytoma (PA), metastatic brain tumors (Mets) and glioblastoma (GBM). TEM1/33 and mouse anti-fibronectin antibodies were used. (-) no staining; (+) weak staining or 10% vessels; (++) moderate staining or approximately 50% of vessels; and (+++) strong staining or nearly 100% of vessels.
###end p 44
###begin p 45
###xml 195 211 195 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 275 283 275 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ </italic>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 417 433 417 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 671 687 671 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 694 695 694 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 722 738 722 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 780 796 780 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 932 933 932 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 901 908 <span type="species:ncbi:9606">patient</span>
As astrocytomas account for more than half of primary CNS malignancies, we expanded our examination to a larger group of primary astrocytic brain tumors in order to look for associations between TEM1/endosialin expression and clinically relevant pathologic features. We used in situ hybridization to probe expression of 275 arrayed grade II-grade IV astrocytic tumors. The results are summarized in Table 2. Overall, TEM1/endosialin expression was detected in 79% of tumor samples (Table 2). When we focused on the grade IV astrocytomas (GBMs) alone, which constitute the most aggressive and lethal subtype, 31% of the tumors demonstrated moderate to strong staining for TEM1/endosialin (Table 2). These data confirm that TEM1/endosialin is widely expressed in astrocytic tumors. TEM1/endosialin expression in grade II-IV astrocytomas demonstrated a statistically significant inverse correlation with patient age (p = 0.004) (Table 2), although it showed no correlation with other common measures such as tumor proliferation index (MIB-1) or apoptotic rate.
###end p 45
###begin p 46
###xml 14 30 14 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
Expression of TEM1/endosialin in grade II-IV astrocytoma microarray.
###end p 46
###begin p 47
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTE</italic>
###xml 163 179 163 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 216 223 <span type="species:ncbi:9606">patient</span>
NOTE: Positive staining as measured by ISH was defined as: weak or 10% of vessels; moderate or approximately 50% of vessels; and strong or nearly 100% of vessels. TEM1/endosialin expression inversely correlated with patient age in grade II-IV astrocytomas for which age data was available, p = 0.004, Mann-Whitney test. SD: standard deviation.
###end p 47
###begin title 48
Co-localization of TEM1/endosialin and fibronectin
###end title 48
###begin p 49
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 805 806 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 827 828 827 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
Fibronectin (FN), collagen I and collagen IV were recently identified as potential binding partners for TEM1/endosialin [11]. We therefore stained the same GBM/metastatic brain tumor tissue array for FN to see if there was a correlation between TEM1/endosialin and FN expression patterns. TEM1/endosialin and FN were co-upregulated in some tumors, although the correlation was not consistent (Table 1). A similar pattern of upregulation was noted for collagen I and collagen IV (YL, unpublished data). Using immunofluorescence, we detected limited co-localization of TEM1/endosialin and FN in GBM and metastatic brain tumor sections, suggesting that physiologic interactions between TEM1/endosialin and FN may occur, but that such interactions are not extensive in clinical settings of CNS neoplasia (Fig 2 and Additional file 1). Similar results were obtained using a custom synthesized, affinity purified anti-TEM1 antibody or commercial antibodies, targeting 3 different epitopes within the protein.
###end p 49
###begin p 50
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Immunofluorescence for TEM1/endosialin: co-localization in tumor specimens</bold>
###xml 193 198 <span type="species:ncbi:9606">human</span>
Immunofluorescence for TEM1/endosialin: co-localization in tumor specimens. TEM1 and CD31 (top panel), alphaSMA (middle panel) and fibronectin (FN, bottom panel) co-localize to microvessels in human GBMs, but demonstrate limited cellular overlap. Anti-TEM1 (TEM1/33), red. Anti-CD31, anti-alphaSMA and anti-FN, green. Nuclei, blue. Scale bar, 20 mum.
###end p 50
###begin title 51
Regulation of TEM1/endosialin expression in vitro
###end title 51
###begin p 52
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 627 628 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 832 833 828 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 902 907 898 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 910 911 906 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1000 1005 996 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1115 1117 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
TEM1/endosialin was originally characterized as an endothelial cell marker, although recent studies have provided evidence for its expression in endothelial progenitor cells, mesenchymal stem cells, tumor pericytes, all of which contribute to the tumor vasculature, and a subpopulation of tumor stromal cells [8,10,17-20]. Co-immunofluorescence for TEM1/endosialin and the pericyte marker alpha-smooth muscle actin (alphaSMA) in the microvasculature of our GBMs and metastatic brain tumors revealed minimal overlap of the two proteins at the cellular level, although the markers did routinely track along the same vessels (Fig 2). Co-immunofluorescence for TEM1/endosialin and CD31, an endothelial marker, also demonstrated limited co-localization of the two proteins, although again both proteins were found on shared vessels (Fig 2). Our results differ in degree slightly from those of Simonavicius, et al. [5], but this may be due to differences in antibodies, tissue fixation conditions (Rouleau et al. experienced significantly different TEM1/endosialin staining results from FFPE versus frozen tumor tissues [21]) or clinical tumor heterogeneity.
###end p 52
###begin p 53
###xml 47 63 47 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 171 187 171 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 619 621 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 735 751 732 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 818 834 815 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 968 970 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1022 1038 1019 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1117 1133 1114 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1251 1267 1248 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1325 1327 1322 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
###xml 1499 1515 1496 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
###xml 1186 1191 <span type="species:ncbi:9606">human</span>
We wished to determine factors that may induce TEM1/endosialin in the endothelium of human brain tumors in order to further clarify the role of this protein. Little or no Tem1/endosialin induction was detected in human microvascular endothelial cells (HMVECs) or human brain microvascular endothelial cells (HBMECs) after exposure to pro-angiogenic growth factors, including vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-beta), insulin-like growth factor 1 (IGF1), stem cell factor (SCF), stromal cell-derived factor 1 (SDF-1) and scatter factor/hepatocyte growth factor (SF/HGF) (Fig 3A). Likewise, culturing primary endothelial cells under hypoxic conditions (2% oxygen for 24 hours) did not induce TEM1/endosialin expression (YL, unpublished data). Since it has been proposed that TEM1/endosialin may interact with proteins within the extracellular matrix as well as tumor stromal cells to promote vascular invasion and migration [11], we examined the effects of growth in matrigel on TEM1/endosialin expression in HMVEC cells. After 6 hours in matrigel, cells were harvested and TEM1/endosialin expression was assessed by quantitative RT-PCR using human specific primers. HMVEC cells cultured in matrigel induced TEM1/endosialin ten-fold compared to HMVEC cells cultured on plastic (Fig 3B). No expression was detected in reverse transcriptase negative samples or in matrigel-only control isolates. This suggests that microvascular endothelial cells can induce TEM1/endosialin when exposed to a complex extracellular environment.
###end p 53
###begin p 54
###xml 14 30 14 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression of <italic>TEM1/endosialin </italic>by cultured endothelial cells</bold>
###xml 78 94 78 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 315 331 315 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 361 377 361 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
Expression of TEM1/endosialin by cultured endothelial cells. A. Expression of TEM1/endosialin after treatment of endothelial cells with pro-angiogenic growth factors. Cells were treated for 48 hours (see Methods) and analyzed by quantitative RT-PCR. Error bars, standard error of the mean. No significant change in TEM1/endosialin was detected. B. Induction of TEM1/endosialin after growth of endothelial cells in matrigel. Cells were grown on plastic (Control) or in matrigel (Matrigel) for 6 hours then analyzed by quantitative RT-PCR. Error bars, standard error of the mean. *p = 0.05. After 6 hours on matrigel and prior to harvest, HMVEC cells demonstrate branching tubulogenesis (lower right) while cells grown on plastic do not (lower left).
###end p 54
###begin title 55
TEM1/endosialin is induced in intracranial GBM xenografts
###end title 55
###begin p 56
###xml 37 53 37 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 157 173 157 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 285 301 285 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 440 448 440 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ </italic>
###xml 520 536 520 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 616 632 616 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 744 760 744 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 214 219 <span type="species:ncbi:10090">mouse</span>
###xml 355 360 <span type="species:ncbi:9606">Human</span>
###xml 429 438 <span type="species:ncbi:10090">nude mice</span>
###xml 468 473 <span type="species:ncbi:10090">mouse</span>
###xml 514 519 <span type="species:ncbi:10090">mouse</span>
###xml 610 615 <span type="species:ncbi:10090">mouse</span>
###xml 709 714 <span type="species:ncbi:10090">mouse</span>
###xml 905 910 <span type="species:ncbi:9606">human</span>
Previous studies demonstrated robust TEM1/endosialin induction in B16 melanoma and HCT116 colon carcinoma xenografts grown in mice, while very low levels of TEM1/endosialin expression were reported in normal adult mouse brain [9]. We therefore sought to determine whether induction of TEM1/endosialin was conserved in an intracranial GBM xenograft model. Human U87MG glioblastoma cells were implanted intracranially into athymic nude mice. In situ hybridization using mouse specific riboprobes was used to measure mouse TEM1/endosialin expression in the subsequently harvested tumors. The results demonstrated mouse TEM1/endosialin induction in the vasculature of the tumor, but not in the surrounding normal mouse brain (Fig 4A). Staining for TEM1/endosialin was often concentrated near the margin of the tumor, although this observation did not reach statistical significance, a characteristic noted in human brain tumors as well (BNW, unpublished data).
###end p 56
###begin p 57
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Tem1/endosialin </italic>expression in mouse brain tumor models</bold>
###xml 72 88 72 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 185 201 185 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 376 392 376 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 443 445 443 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5 </sup>
###xml 609 625 609 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 700 716 699 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
###xml 130 139 <span type="species:ncbi:10090">nude mice</span>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
###xml 236 241 <span type="species:ncbi:10090">mouse</span>
###xml 265 270 <span type="species:ncbi:10090">mouse</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
Tem1/endosialin expression in mouse brain tumor models. A. Induction of Tem1/endosialin in intracranial U87MG xenografts grown in nude mice. ISH with mouse specific riboprobes detected Tem1/endosialin (Tem1) in tumor (T) but not normal mouse brain (NL). Probes for mouse vWF were used as a positive endothelial control (vWF). Original magnification, 200x. B. Survival of nude TEM1/endosialin WT and KO mice after intracranial injection with 105 U87MG glioblastoma cells. Animals sacrificed after 100 days showed no evidence of tumor take. C. Tumor vessels stained for vWF in intracranial xenografts from nude TEM1/endosialin WT or KO mice. Size bar, 50 mum. D. Comparison of vessel numbers from nude TEM1/endosialin WT and KO tumors. Ten non-overlapping high power fields were counted per animal. Error bars, standard error of the mean. *p = 0.001.
###end p 57
###begin title 58
Tem1/endosialin expression is not required for brain tumor growth in vivo
###end title 58
###begin p 59
###xml 45 61 45 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 187 203 187 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 274 290 274 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4B</xref>
###xml 421 437 421 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
In order to investigate whether induction of Tem1/endosialin is required for tumorigenesis and/or angiogenesis in brain tumors, we injected U87MG human GBM cells intracranially into nude Tem1/endosialin KO and WT mice. No significant difference in survival time between the Tem1/endosialin KO and WT animals was detected (Fig 4B). Neither was there a detectable difference in tumor take or volume. We were able to detect Tem1/endosialin in the vasculature of the WT, but not the KO, tumors, confirming the genotype of the mice.
###end p 59
###begin p 60
###xml 6 22 6 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 132 148 132 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 189 204 189 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin</italic>
###xml 236 252 236 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 264 272 264 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ </italic>
###xml 434 450 434 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 183 188 <span type="species:ncbi:9606">human</span>
Since TEM1/endosialin expression has been noted in tumor stromal cells, as well as vascular and perivascular cells, we screened the Tem1/endosialin KO and WT tumors for expression of human TEM1/endosialin. We did not detect appreciable TEM1/endosialin staining by in situ hybridization in the tumor stroma of either the knockout or wildtype xenografts. This suggests that growth of the intracranial xenografts was not supplemented by TEM1/endosialin expression from the U87MG tumor cells themselves.
###end p 60
###begin p 61
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 121 137 121 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 301 317 301 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 412 417 412 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4C, D</xref>
###xml 484 500 484 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 726 742 722 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
Nanda, et al., reported increased numbers of microvessels in xenografted colon carcinomas grown in the intestine of nude Tem1/endosialin knockout mice as compared to their wildtype counterparts [13]. We therefore examined the intracranial U87MG xenografts for a similar phenotype. The tumors from the Tem1/endosialin KO animals had approximately 40% more vessels than the tumors grown in the wildtype mice (Fig. 4C, D). This suggests that although GBM xenografts grew normally in the Tem1/endosialin knockout animals, tumor angiogenesis was nevertheless altered. Staining with antibodies to alphaSMA did not demonstrate any difference in pericyte coverage between the WT and KO tumor vessels (MCW, unpublished data). So while Tem1/endosialin is not required for overall growth of this intracranial brain tumor model, it does appear to be required for normal development of the tumor cerebrovasculature, although the mechanism for this remains unclear.
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin/CD248 </italic>
###xml 170 186 170 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 312 328 312 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 568 569 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 574 575 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 580 581 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 593 595 593 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 641 642 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 647 649 647 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 665 666 665 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 678 680 678 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1035 1051 1035 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1052 1054 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1071 1087 1071 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1737 1742 1737 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1950 1952 1950 1952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1960 1965 1960 1965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2131 2133 2131 2133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 2184 2200 2184 2200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 881 886 <span type="species:ncbi:9606">Human</span>
###xml 938 942 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
TEM1/endosialin/CD248 encodes a 165 kD single-pass transmembrane glycoprotein. It is a C-lectin type receptor with homology to thrombomodulin. Several studies identified TEM1/endosialin as a marker of tumor endothelium and isolated activated fibroblasts within the tumor stroma [7,9]. Little to no expression of TEM1/endosialin was noted in normal adult tissues. Alternate studies have argued that TEM1/endosialin in the tumor vasculature is expressed by vessel-associated pericytes [8,10,19]. Two additional reports identified TEM1/endosialin in populations of VEGFR2+/CD31+/CD45-/VE-cadherin+ endothelial precursor cells derived from CD133+/CD34+ cells or in CD45+/VE-cadherin+ "vascular leukocytes" [20,22]. Both cell types have been proposed to contribute to tumor vascularization, although the degree to which either one incorporates into tumor vessels remains controversial. Human umbilical vein endothelial cells immortalized with SV40 large/small T-antigen, a model of proliferating neovascular endothelial cells, also express TEM1/endosialin [23]. We argue that TEM1/endosialin is expressed to varying degrees by tumor endothelial cells, pericytes and stromal fibroblasts. In normal blood vessels, the pericytes bind tightly to endothelial cells and influence migration, stabilization and maturation of the endothelium. In the cerebrovasculature, pericytes are additionally critical for maintenance of the differentiated blood-brain barrier (BBB) and failure of the BBB in brain tumors is associated with disruption and loss of pericytes lining endothelial cells. Pericytes are of emerging interest as therapeutic targets as vessels may be more sensitive to chemotherapy or radiotherapy when denuded of pericytes. When Bergers, et al., targeted both the endothelial cell and pericyte compartments with combinatorial receptor tyrosine kinase inhibitory (RTKI) therapies, they achieved more favorable responses than with either therapy alone [24]. Cao, et al., demonstrated that systemic overexpression of Ang2 blocked pericyte recruitment to tumor vessels and led to massive vascular destabilization and tumor suppression [25]. The collective data support the hypothesis that TEM1/endosialin has a favorable expression profile for targeting both the endothelial and pericytic portions of the tumor vasculature.
###end p 63
###begin p 64
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 900 901 897 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 906 908 903 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 944 946 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1029 1045 1026 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 532 538 <span type="species:ncbi:10090">murine</span>
Expression of TEM1/endosialin by a subset of tumor fibroblasts may also influence tumor growth and angiogenesis. Activated tumor fibroblasts contribute to the deposition of fibronectin, collagen I and collagen IV, all of which may bind TEM1/endosialin and guide vessel invasion, migration or differentiation. SDF-1 expression by activated tumor fibroblasts has been shown to drive tumor progression and angiogenesis in breast carcinoma models and has been reported to recruit endothelial progenitor cells to the microvasculature of murine gliomas, where differentiation into both pericytes and endothelium was detected [26,27]. A recent genetic study reported that TGFbeta1 treatment of proliferating endothelial cells led to an endothelial-mesenchymal transition, wherein endothelial cells downregulated CD31 and upregulated fibroblast-specific protein-1 (FSP-1). They confirmed the presence of FSP1+/CD31+ intermediate cells in tumor models [28]. Further work is necessary to fully determine the complete expression profile of TEM1/endosialin and its relationship to these intricately related stromal cell populations.
###end p 64
###begin p 65
###xml 449 465 449 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 592 608 592 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 670 686 670 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 916 931 916 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin</italic>
###xml 975 991 975 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1060 1075 1060 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin</italic>
###xml 1435 1451 1435 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 1741 1756 1741 1756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin</italic>
###xml 2058 2074 2058 2074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 2206 2207 2206 2207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 2359 2375 2359 2375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 2552 2554 2552 2554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 2619 2635 2619 2635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
###xml 481 486 <span type="species:ncbi:9606">human</span>
###xml 1220 1225 <span type="species:ncbi:10090">mouse</span>
###xml 1382 1387 <span type="species:ncbi:10090">mouse</span>
###xml 2406 2413 <span type="species:ncbi:9606">patient</span>
In the US, primary brain tumors are diagnosed in approximately 40,000 new patients a year. In addition, brain metastases occur in 20-40% of cancer patients, leading to 200,000-400,000 new cases of brain metastases a year. Despite differences in the molecular fingerprints of the tumor cells themselves, it may be possible to identify common changes in the vasculature of these disparate tumor types. Initial studies by ourselves and others reported TEM1/endosialin upregulation in human brain tumors [1,5,7]. We wanted to expand these findings in order to better establish the full extent of TEM1/endosialin expression in brain tumors. This study confirms expression of TEM1/endosialin at the RNA and protein level in astrocytic and metastatic brain tumors, with little to no expression in normal control brain. Expression was primarily limited to the tumor vasculature but occasional stromal cells also stained for TEM1/endosialin. Greater than 30% of GBMs displayed robust TEM1/endosialin expression, while lesser percentages of lower grade tumors expressed TEM1/endosialin. Unfortunately, we did not know whether the individual specimens analyzed were from the tumor center or closer to the tumor margin. Preliminary mouse xenograft data suggested that Tem1/endosialin staining was increased along the tumor margin, but this needs to be further investigated in both clinical and mouse tumors. It will be especially useful to assess Tem1/endosialin expression in future experiments using xenografted primary glioma spheroids or glioma stem cells, which grow as a more highly invasive intracranial tumor than the U87 model, although with less pronounced angiogenesis. Interestingly, one pilocytic astrocytoma displayed robust expression of TEM1/endosialin. Although pilocytic astrocytomas are considered low-grade tumors, they are highly angiogenic and often enhance on MRI, which is indicative of vascular leakiness, disruption of the blood-brain barrier and often more aggressive disease. A recent study in breast cancer identified an association between TEM1/endosialin expression and progressive and/or recurrent disease as well as nodal involvement, all hallmarks of a more aggressive disease state [6]. Thus, TEM1/endosialin may have prognostic value for breast cancer. We did detect a statistically significant (p = 0.004) inverse correlation between TEM1/endosialin expression in astrocytomas and patient age, although the implications of this remain unclear. While diagnosis at a younger age can be a predictor of long-term survival for GBM [29], our initial analyses reveal no difference in survival between TEM1/endosialin expressing and non-expressing tumors.
###end p 65
###begin p 66
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1026 1027 1026 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1774 1776 1774 1776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1935 1937 1935 1937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1938 1940 1938 1940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1947 1956 1947 1956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 755 760 <span type="species:ncbi:9606">human</span>
###xml 1973 1978 <span type="species:ncbi:9606">human</span>
Tomkowicz, et al. recently identified collagen types I and IV and fibronectin as potential ligands for TEM1/endosialin [11]. They showed that CHO cells engineered to overexpress TEM1/endosialin (CHO-TEM1) exhibited greater adhesion to fibronectin than control CHO cells (CHO-K1). They suggested a model by which TEM1/endosialin is induced in cells associated with endothelium and stromal fibroblasts. The subsequent interactions between TEM1/endosialin expressing cells and fibronectin, collagen I or IV present in the extracellular matrix drive cellular migration required for tumor invasion and angiogenesis. In an independent study, TEM1/endosialin and collagen IV were shown to colocalize in finger-like processes during angiogenic development in the human fetal telencephalon [30]. We had identified collagen I and collagen IV as putative glioma endothelial markers which exhibited a minimum 4-fold induction as compared to normal endothelial cell samples and were induced in both glioma and colon carcinoma endothelium [1]. Therefore, we were curious to determine whether we could detect co-localization of fibronectin with TEM1/endosialin in our primary and secondary tumor samples. We did detect upregulation of both TEM1/endosialin and fibronectin within the same tumor specimens, although only a subset of the samples showed co-localization along the vasculature, supporting a physiologic interaction of these proteins. In addition, Tomkowicz and colleagues showed that the CHO-TEM1 cells, but not CHO-K1 control cells, grew with web-like morphology and formed large clusters when cultured in matrigel. The CHO-TEM1 cells also exhibited enhanced migration through matrigel that was blocked by incubation with a humanized antibody targeted against TEM1/endosialin [11]. Others have shown that incubation with anti-TEM1/endosialin antibodies can block tube formation by endothelial progenitor cells and mesenchymal stem cells [17,20]. Our in vitro data showed that human endothelial cells grown in matrigel induce TEM1/endosialin themselves in response to the culture environment. Together, the biochemical and localization data support a functional role for TEM1/endosialin in promoting cell-cell interactions and migration during tumor angiogenesis.
###end p 66
###begin p 67
###xml 32 48 32 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 86 102 86 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 188 204 188 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 325 341 325 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 692 707 692 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin</italic>
###xml 757 773 757 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 686 691 <span type="species:ncbi:9606">human</span>
###xml 789 794 <span type="species:ncbi:10090">mouse</span>
Since the expression profile of TEM1/endosialin and existent xenograft data suggested TEM1/endosialin might be a viable therapeutic target for brain tumors, we wished to ascertain whether TEM1/endosialin induction was conserved in an orthotopic model of GBM. Intracranial U87MG xenografts demonstrated robust upregulation of Tem1/endosialin in the tumor vasculature with little to no expression in non-neoplastic brain. Again, staining was predominantly present in the vessels, although we could detect staining in occasional tumor stromal cells. Interestingly, when we implanted U87MG cells engineered to stably overexpress VEGF, a small percentage of tumor cells stained positive for human TEM1/endosialin, although there was no significant difference in Tem1/endosialin staining in the mouse vessels (BNW, unpublished data).
###end p 67
###begin p 68
###xml 56 72 56 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 471 487 471 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 814 819 814 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 900 909 900 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1441 1457 1441 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1617 1633 1617 1633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
When we implanted intracranial GBM xenografts into nude Tem1/endosialin KO and WT mice, we detected no difference in tumor take or survival. This differs from the colon carcinoma data and suggests that the impact of Tem1/endosialin in the cerebral microenvironment may differ from its role in intestinal tumorigenesis. Nanda, et al., reported a significant decrease in tumor take and volume when they implanted colon carcinoma xenografts into the large intestine of nude Tem1/endosialin KO mice [13]. However, they did not detect a difference in tumor growth when identical cells were implanted subcutaneously into KO and WT animals. They argued that this emphasized the importance of an anatomically relevant microenvironment for tumor growth and study. This is a similar argument to that proposed by Camphausen, et al., who compared the expression profiles of U87MG and U251MG GBM cell lines grown in vitro to those from cells grown as subcutaneous or intracranial xenografts [31]. They noted that the expression profiles in tissue culture were significantly different from the subcutaneous profiles, which were, in turn, distinct from the intracranial expression profiles. The disparity between GBM xenograft expression profiles suggested that the orthotopic implantation site can dictate gene expression, presumably due to signaling between the tumor cells and the surrounding stroma. In the current scenario, it would again appear that TEM1/endosialin expression levels within distinct anatomical compartments differentially influence tumor growth and pathology. Importantly, the data suggest that inhibition of TEM1/endosialin function alone in tumors is insufficient for suppression of brain tumor growth.
###end p 68
###begin p 69
###xml 70 86 70 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 643 659 643 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 688 704 688 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEM1/endosialin </italic>
###xml 1027 1043 1027 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tem1/endosialin </italic>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 937 942 <span type="species:ncbi:10090">mouse</span>
Despite unchanged tumor growth and equivalent animal survival between Tem1/endosialin WT and KO animals, we did detect an increase in the number of microvessels present in the KO GBM tumors. This strengthens a role for TEM1/endosialin in the maturation of the tumor neo-vasculature [13]. TEM1/endosialin was recently reported to be upregulated by hypoxia via a HIF-2 pathway in a limited number of cell lines, although we could detect no induction in primary human endothelial cells [32]. However, the brain is a highly vascularized site, and it may be that the level of oxygenation is sufficient to promote xenograft growth in the absence of Tem1/endosialin induction. It is more likely TEM1/endosialin is directly or indirectly required for differentiation or maturation of the vasculature, as opposed to strict proliferation, and that lack of TEM1/endosialin protein leads to the overabundance of vessels demonstrated in the knockout mouse tumors. Further studies are needed to determine if the increased vascularity of the Tem1/endosialin KO tumors could render them more sensitive to radiation or chemotherapy, by enhancing the delivery of radiosensitizing oxygen or therapeutic drugs.
###end p 69
###begin title 70
Conclusion
###end title 70
###begin p 71
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
The combined tumor data confirm that TEM1/endosialin contributes to the development of the brain tumor vasculature. Although lack of TEM1/endosialin expression did not inhibit brain tumor growth in our model, the cell surface bioavailability of TEM1/endosialin and its localization to tumor and tumor vasculature components in both primary and metastatic brain tumors, both diseases with limited current treatment options, support efforts to target this protein with alternative approaches, including antibody or antibody-cytotoxin based strategies, such as a recently reported anti-TEM1/endosialin IgG conjugated to saporin, and other efforts in pre-clinical development [11,21,33] or as combination therapy.
###end p 71
###begin title 72
Competing interests
###end title 72
###begin p 73
The authors declare that they have no competing interests.
###end p 73
###begin title 74
Authors' contributions
###end title 74
###begin p 75
EBC-W designed the studies, contributed ISH and IH experiments and analysis and wrote the manuscript. BNW participated in IH and cell culture experiments and analysis. MCW performed IF experiments and analysis. YL participated in cell culture and gene expression experiments. HH and SJ collected astrocytoma samples, performed microarray experiments and statistical analysis. BMT and DLH performed the animal experiments. MDJ participated in microtissue array construction and pathologic consultation. KAW participated in experimental design, analysis and interpretation and edited the manuscript. All authors have seen and approved the manuscript.
###end p 75
###begin title 76
Pre-publication history
###end title 76
###begin p 77
The pre-publication history for this paper can be accessed here:
###end p 77
###begin p 78

###end p 78
###begin title 79
Supplementary Material
###end title 79
###begin title 80
Additional file 1
###end title 80
###begin p 81
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Co-localization of TEM1/endosialin with fibronectin in clinical brain tumor specimens</bold>
Co-localization of TEM1/endosialin with fibronectin in clinical brain tumor specimens. Additional immunofluorescence results demonstrating limited co-localization of TEM1/endosialin and fibronectin in GBM using commercial anti-TEM1/endosialin antibodies.
###end p 81
###begin p 82
Click here for file
###end p 82
###begin title 83
Acknowledgements
###end title 83
###begin p 84
This work was supported by the National Institute of Neurologic Disease and Stroke K08 NS046461 (K. Walter), Elsa U Pardee Foundation (K. Walter), Neurosurgery Research and Education Foundation (K. Walter), the Ronald L. Bittner Brain Tumor Research Fund (K. Walter), the Copeland Fund of the Pittsburgh Foundation (E. Carson-Walter, K. Walter), and American Brain Tumor Association (K. Walter).
###end p 84
###begin article-title 85
Vascular gene expression in nonneoplastic and malignant brain
###end article-title 85
###begin article-title 86
###xml 19 24 <span type="species:ncbi:9606">human</span>
Genes expressed in human tumor endothelium
###end article-title 86
###begin article-title 87
Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium
###end article-title 87
###begin article-title 88
###xml 91 96 <span type="species:ncbi:9606">human</span>
Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer
###end article-title 88
###begin article-title 89
Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma
###end article-title 89
###begin article-title 90
###xml 132 140 <span type="species:ncbi:9606">patients</span>
Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors
###end article-title 91
###begin article-title 92
Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium
###end article-title 92
###begin article-title 93
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 65 71 <span type="species:ncbi:9606">humans</span>
Cell surface tumor endothelial markers are conserved in mice and humans
###end article-title 93
###begin article-title 94
Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells
###end article-title 94
###begin article-title 95
Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration
###end article-title 95
###begin article-title 96
Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K
###end article-title 96
###begin article-title 97
Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors
###end article-title 97
###begin article-title 98
Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis
###end article-title 98
###begin article-title 99
Peroxiredoxins and antioxidant enzymes in pilocytic astrocytomas
###end article-title 99
###begin article-title 100
Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood-brain barrier disruption in rodent models
###end article-title 100
###begin article-title 101
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers
###end article-title 101
###begin article-title 102
Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization
###end article-title 102
###begin article-title 103
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development
###end article-title 103
###begin article-title 104
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248
###end article-title 104
###begin article-title 105
###xml 66 71 <span type="species:ncbi:9606">human</span>
Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma
###end article-title 105
###begin article-title 106
Vascular leukocytes contribute to tumor vascularization
###end article-title 106
###begin article-title 107
###xml 30 35 <span type="species:ncbi:9606">human</span>
Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs
###end article-title 107
###begin article-title 108
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
###end article-title 108
###begin article-title 109
Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth
###end article-title 109
###begin article-title 110
Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes
###end article-title 110
###begin article-title 111
###xml 40 45 <span type="species:ncbi:9606">human</span>
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
###end article-title 111
###begin article-title 112
Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts
###end article-title 112
###begin article-title 113
Long-term survival with glioblastoma multiforme
###end article-title 113
###begin article-title 114
###xml 92 97 <span type="species:ncbi:9606">human</span>
An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis
###end article-title 114
###begin article-title 115
###xml 31 36 <span type="species:ncbi:9606">human</span>
Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions
###end article-title 115
###begin article-title 116
###xml 34 39 <span type="species:ncbi:9606">human</span>
Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2
###end article-title 116
###begin article-title 117
Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy
###end article-title 117

